Summary & Overview
HCPCS G0123: Screening Cytopathology, Thin-Layer Cervical/Vaginal
HCPCS Level II code G0123 covers automated thin-layer screening cytopathology of cervical or vaginal specimens collected in preservative fluid, with initial review by a cytotechnologist under physician supervision. This code represents a common preventive screening service in women's health and pathology laboratories and is important nationally for cervical cancer screening programs and quality measurement in cytology services. Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and laboratory workflow for this screening procedure, typical sites of service, and commonly applied billing modifiers. The publication summarizes reimbursement benchmark considerations, payer coverage trends, and coding practice points relevant to laboratories, pathology groups, and outpatient providers. The content also highlights areas where policy updates or payer-specific guidelines may affect billing and documentation. Data not available in the input for payer-specific rates, taxonomies, related codes, and ICD-10 mapping are noted as unavailable.
Billing Code Overview
HCPCS Level II code G0123 describes screening cytopathology of cervical or vaginal specimens collected in preservative fluid with automated thin layer preparation, where the initial screening is performed by a cytotechnologist under physician supervision. This service is a screening cytology laboratory test aimed at detecting cellular abnormalities of the cervix or vagina.
-
Service type: Screening cytopathology laboratory service
-
Typical site of service: Clinical laboratory or pathology laboratory associated with outpatient clinics, gynecology offices, or hospital outpatient departments
Clinical & Coding Specifications
Clinical Context
A 32-year-old woman presents to a primary care clinic for routine cervical cancer screening. A clinician collects a cervical specimen using a brush and places the sample into a liquid preservative vial for an automated thin-layer preparation (liquid-based cytology). The specimen is labeled and sent to the on-site laboratory. A cytotechnologist performs the initial screening of the thin-layer slide under the supervision of a pathologist/physician, reviewing for adequacy and cytologic abnormalities. If the screening cytology is abnormal or unsatisfactory, reflex testing or physician review is documented and further diagnostic steps (HPV testing, colposcopy, biopsy) are ordered per clinical protocols. Billing for the laboratory screening service uses the HCPCS Level II code G0123 to indicate screening cytopathology collected in preservative fluid with automated thin layer preparation, screened by a cytotechnologist under physician supervision. Typical site of service is an outpatient clinic, physician office, or hospital outpatient laboratory. Typical modifiers applied depend on payer and clinical circumstances (professional component, technical component, unusual services, patient status, or payer-specific reporting). Typical patient scenario: asymptomatic adult undergoing routine preventive screening; specimen adequate for interpretation and screened by cytotechnologist with documented supervisory physician oversight.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 |